A nurse is caring for a patient receiving norepinephrine (Levophed) infusion for septic shock. Which assessment finding would be the priority concern requiring immediate intervention?

In septic shock, norepinephrine is the first-line vasopressor used to counteract profound vasodilation and maintain perfusion pressure. While traditionally administered through central venous catheters due to the risk of extravasation injury, peripheral administration is increasingly common in early resuscitation. However, this practice demands vigilant monitoring for local complications.

When a patient on a vasopressor infusion develops a change at the IV site, the nurse must immediately recognize that extravasation of a vasoconstrictor like norepinephrine can cause severe local tissue ischemia and necrosis. The priority concern is always the integrity of the infusion site because ongoing leakage of the drug into surrounding tissues will cause progressive, irreversible damage. The systematic review and meta-analysis by Wu et al. confirms that extravasation is a primary safety concern when vasopressors are infused through peripheral intravenous catheters, with a pooled prevalence that underscores the clinical significance of this complication ^[2]. The evidence summary by Chen et al. further emphasizes that peripheral administration of vasopressors carries explicit risks of extravasation and phlebitis, making site assessment a critical nursing responsibility ^[1].

Let us analyze each assessment finding to understand the clinical reasoning behind the priority ranking.

Option 1: Blood pressure reading of 95/60 mmHg. A mean arterial pressure (MAP) of approximately 72 mmHg is at the lower boundary of the initial target (typically MAP ≥ 65 mmHg) for septic shock resuscitation. While this finding indicates that the current norepinephrine dose may be insufficient and requires titration, it represents the expected therapeutic challenge of managing shock. It is a concern that requires intervention, but it is not immediately life-threatening in the same way as ongoing tissue destruction from a vesicant drug.

Option 2: Heart rate of 110 beats per minute. Tachycardia is an expected compensatory response to decreased systemic vascular resistance and hypotension in septic shock, and it is also a known beta-adrenergic effect of norepinephrine. This finding requires continued monitoring but is a predictable physiological response, not an acute local crisis.

Option 3: Urine output of 25 mL per hour. Oliguria (defined as urine output less than 0.5 mL/kg/hour) signals inadequate renal perfusion and is a key indicator that the vasopressor therapy has not yet achieved hemodynamic optimization. This finding validates the need for ongoing resuscitation and dose adjustment but does not present an immediate threat of local tissue loss.

Option 4: Blanching and coolness at the IV insertion site. These are the classic early signs of extravasation of a vasoconstrictor. Blanching indicates that the infused norepinephrine is causing intense local vasoconstriction outside the vein, and coolness reflects the resulting tissue ischemia. This is a medical emergency at the site. If the infusion is not stopped immediately, the ischemia can progress to necrosis, leading to severe tissue damage that may require surgical debridement or grafting. The protocol for the prospective cohort study by Gao et al. is built upon the very premise that the primary concern with peripheral vasopressor infusion is the potential for extravasation and local tissue injury . A retrospective study by Karlsson et al. on midline catheter administration also identifies extravasation as the critical complication driving the traditional requirement for central line administration . This finding demands the most immediate nursing action: stopping the infusion, aspirating the drug if possible, and initiating site-specific antidote protocols.

Using the nursing prioritization framework, the local complication of extravasation takes precedence over the systemic findings of suboptimal hemodynamics. The rationale is that a MAP of 72 mmHg, tachycardia, and oliguria all represent a state of compensated or under-resuscitated shock that can be managed over minutes to hours with titration. In contrast, the blanching and coolness at the IV site indicate active, ongoing tissue injury that worsens with every second the infusion continues. Delaying intervention to address blood pressure first would allow the norepinephrine to cause a larger area of ischemic necrosis, resulting in permanent patient harm. The evidence consistently identifies extravasation as the sentinel safety event in peripheral vasopressor administration, making its early recognition and immediate intervention the highest clinical priority ^[1][2].